{"SPADE_N_07182": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_07182", "Peptide Name": "pTnI", "Source": "Troponin I", "Family": "", "Gene": "Not found", "Sequence": "EDMNQKLFDLRGKFKRPPLRRVRMSADAML", "Sequence Length": 30, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C157H264N50O42S3", "Mass": 3620.28, "PI": 10.88, "Net Charge": 4, "Hydrophobicity": -0.84, "Half Life": "Mammalian:1 hourYeast:30 minE.coli:>10 hour", "Literature": [{"Title": "Anti-angiogenic peptides for cancer therapeutics", "Pubmed ID": "21470139", "Reference": "Curr Pharm Biotechnol. 2011 Aug;12(8)1101-23.", "Author": "Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21470139"}], "Frequent Amino Acids": "RLD", "Absent Amino Acids": "CHIOTUWY", "Basic Residues": 8, "Acidic Residues": 4, "Hydrophobic Residues": 14, "Polar Residues": 14, "Positive Residues": 8, "Negative Residues": 4, "Similar Sequences": []}}}